Navidea eyes Europe for Lymphoseek

06/30/2013 | American City Business Journals

Navidea Biopharmaceuticals is working to secure European approval for its imaging agent Lymphoseek by the end of 2013. The company also said it has chosen a "specialty pharmaceutical company" as a potential distribution partner for Europe. Company President and Chief Business Officer Thom Tulip said Navidea is aiming to develop Lymphoseek for additional cancers.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Sr Manager, Business Conduct
Gilead Sciences
Foster City, CA
Chief Executive Officer
UCare Minnesota
Minneapolis, MN